全文获取类型
收费全文 | 185476篇 |
免费 | 4627篇 |
国内免费 | 2203篇 |
专业分类
耳鼻咽喉 | 1827篇 |
儿科学 | 6499篇 |
妇产科学 | 2733篇 |
基础医学 | 20865篇 |
口腔科学 | 6502篇 |
临床医学 | 12849篇 |
内科学 | 33366篇 |
皮肤病学 | 2963篇 |
神经病学 | 11416篇 |
特种医学 | 4132篇 |
外国民族医学 | 2篇 |
外科学 | 27637篇 |
综合类 | 12058篇 |
一般理论 | 8篇 |
预防医学 | 11210篇 |
眼科学 | 3724篇 |
药学 | 21413篇 |
29篇 | |
中国医学 | 7996篇 |
肿瘤学 | 5077篇 |
出版年
2022年 | 1548篇 |
2021年 | 3444篇 |
2020年 | 1830篇 |
2019年 | 13315篇 |
2018年 | 12999篇 |
2017年 | 6171篇 |
2016年 | 1734篇 |
2015年 | 1816篇 |
2014年 | 3960篇 |
2013年 | 6194篇 |
2012年 | 3961篇 |
2011年 | 4099篇 |
2010年 | 3329篇 |
2009年 | 3319篇 |
2008年 | 3874篇 |
2007年 | 4746篇 |
2006年 | 4899篇 |
2005年 | 4703篇 |
2004年 | 3686篇 |
2003年 | 3652篇 |
2002年 | 3522篇 |
2001年 | 3469篇 |
2000年 | 3631篇 |
1999年 | 3254篇 |
1998年 | 3283篇 |
1997年 | 2624篇 |
1996年 | 2437篇 |
1995年 | 2754篇 |
1994年 | 2596篇 |
1993年 | 2048篇 |
1992年 | 1650篇 |
1991年 | 1600篇 |
1990年 | 1331篇 |
1989年 | 1071篇 |
1988年 | 1138篇 |
1987年 | 1072篇 |
1986年 | 906篇 |
1985年 | 5508篇 |
1984年 | 7337篇 |
1983年 | 5862篇 |
1982年 | 6304篇 |
1981年 | 5751篇 |
1980年 | 4950篇 |
1979年 | 5000篇 |
1978年 | 4100篇 |
1977年 | 3081篇 |
1976年 | 3553篇 |
1975年 | 2750篇 |
1974年 | 2542篇 |
1973年 | 2244篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
Guo-Quan Shi Huajun Zhu & Zhen-Guo Yan 《Communications In Computational Physics》2022,31(4):1215-1241
A priori subcell limiting approach is developed for high-order flux reconstruction/correction procedure via reconstruction (FR/CPR) methods on two-dimensional unstructured quadrilateral meshes. Firstly, a modified indicator based on
modal energy coefficients is proposed to detect troubled cells, where discontinuities
exist. Then, troubled cells are decomposed into nonuniform subcells and each subcell has one solution point. A second-order finite difference shock-capturing scheme
based on nonuniform nonlinear weighted (NNW) interpolation is constructed to perform the calculation on troubled cells while smooth cells are calculated by the CPR
method. Numerical investigations show that the proposed subcell limiting strategy on
unstructured quadrilateral meshes is robust in shock-capturing. 相似文献
12.
13.
《Journal of Radiology Nursing》2022,41(3):166-169
PurposeIn 2018, The Journal of Vascular and Interventional Radiology (JVIR) updated its guidelines regarding periprocedural antibiotics. However, some institutions are slower to adopt these new guidelines. Additionally, antibiotic-resistant bacteria and sepsis are serious concerns due in part to incorrect usage of antibiotics. The purpose of this study is to assess institutional adherence to 2018 JVIR guidelines for the purpose of improving antibiotic stewardship.Materials and methodsA total of 800 cases over a 10-month time period were retrospectively identified and charted following the release of guidelines. Inclusion criteria for the study were adults aged 21 years or older undergoing mediport placement, tunneled central line (TCL) placement, nephrostomy tube exchange, percutaneous biliary drain, or cholecystostomy tube exchange. Exclusion criteria included immunocompromised and pregnant individuals as 2018 guidelines may not fit these patient populations. Guideline adherence for each procedure was recorded as a percentage; the timing of the antibiotic usage was also recorded and compared to the guidelines (within 60 minutes before incision).ResultsIn total, 49 mediport placements, 118 tunneled central line placements – 44 hemodialysis (HD) catheters and 74 nonhemodialysis (non-HD) catheters, 100 nephrostomy exchanges, and 82 biliary tube exchanges were included. Antibiotics were used in 83.6% (41/49) of mediport patients, 11.3% (5/44) of non-HD TCL patients, 20.5% (15/74) of HD TCL patients, 55% (55/100) nephrostomy tube changes, and 65.4% (55/84) of biliary or cholecystostomy tube exchanges. Out of those given prophylaxis, guideline-recommended antibiotics were used in 100% (41/41) of mediport, 100% (20/20) of TCL (both HD and non-HD catheters), 9% (5/55) of nephrostomy tube exchanges, and 1.8% (1/55) of biliary tube exchanges. Guideline-recommended timing was followed in 75.3% across all cases (ranging from 72.2% in mediports to 79.3% in biliary exchanges).ConclusionThis study of antibiotic practices at a single university-based academic institution revealed that antibiotic usage is not fully up to date with 2018 guidelines. For mediports, non-HD TCL placements, and nephrostomy tube exchanges, institutional changes should be made to reduce periprocedural antibiotic use, as antibiotics are no longer recommended for these procedures. For HD TCL and biliary exchanges, proper adherence to recommended prophylactic antibiotics should be followed. In addition, education about the correct antibiotic timing should be emphasized to increase compliance with guidelines. 相似文献
14.
15.
16.
17.
18.
19.
《Neurologic Clinics》2019,37(2):425-440
20.
ABSTRACTIn clinical trials, selection of appropriate study endpoints is critical for an accurate and reliable evaluation of safety and effectiveness of a test treatment under investigation. In practice, however, there are usually multiple endpoints available for measurement of disease status and/or therapeutic effect of the test treatment under study. For example, in cancer clinical trials, overall survival, response rate, and/or time to disease progression are usually considered as primary clinical endpoints for evaluation of safety and effectiveness of the test treatment under investigation. Once the study endpoints have been selected, sample size required for achieving a desired power is then determined. It, however, should be noted that different study endpoints may result in different sample sizes. In practice, it is usually not clear which study endpoint can best inform the disease status and measure the treatment effect. Moreover, different study endpoints may not translate one another although they may be highly correlated one another. In this article, we intend to develop an innovative endpoint namely therapeutic index based on a utility function to combine and utilize information collected from all study endpoints. Statistical properties and performances of the proposed therapeutic index are evaluated theoretically. A numerical example concerning a cancer clinical trial is given to illustrate the use of the proposed therapeutic index. 相似文献